WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1509

Summary of SB 1509: Relating to Prescription Drugs

Bill Overview

Bill Number: SB 1509
Introduced On: January 22, 2025
Current Status: Deferred by the committee(s) on CPC as of March 19, 2025
Primary Sponsor: Senator Kouchi
Classification: Legislative Bill
Subject Areas: Pharmacy Benefit Managers, Prescription Drugs, Legislative Reference Bureau, Study

Purpose and Intent

SB 1509 aims to address issues related to prescription drugs, particularly focusing on the role of Pharmacy Benefit Managers (PBMs). The bill seeks to conduct a comprehensive study to evaluate the impact of PBMs on prescription drug pricing and accessibility for consumers. The intent is to enhance transparency and potentially reform practices that may contribute to rising drug costs.

Key Provisions

  • Study Mandate: The bill mandates the Legislative Reference Bureau to conduct a study on the operations of Pharmacy Benefit Managers, including their pricing strategies and the overall effect on drug affordability for consumers.
  • Reporting Requirements: The findings from the study will be compiled into a report, which will be submitted to the legislature for review and potential action.
  • Focus Areas: The study will specifically examine:
    • The pricing mechanisms employed by PBMs.
    • The impact of these mechanisms on consumer access to necessary medications.
    • Recommendations for legislative or regulatory changes based on the study's findings.

Affected Parties

  • Consumers: Individuals who rely on prescription medications may benefit from increased transparency and potential reforms that could lower drug costs.
  • Pharmacy Benefit Managers: PBMs will be directly impacted by the study's findings, which may lead to regulatory changes affecting their operations.
  • Healthcare Providers: Physicians and pharmacists may also be affected as changes in PBM practices could influence prescribing and dispensing medications.

Legislative Timeline

  • January 22, 2025: Bill introduced and passed First Reading.
  • February 24, 2025: The committees on HHS and CPN recommended the bill be passed with amendments.
  • March 6, 2025: The bill was referred to multiple committees, including HLT, CPC, and FIN.
  • March 14, 2025: The bill passed Second Reading as amended and was scheduled for a hearing by the CPC.
  • March 19, 2025: The CPC committee recommended that the measure be deferred.

Conclusion

SB 1509 represents a proactive approach to understanding and potentially reforming the role of Pharmacy Benefit Managers in the prescription drug market. By mandating a study, the bill aims to provide lawmakers with the necessary information to make informed decisions regarding drug pricing and accessibility, ultimately benefiting consumers and the healthcare system as a whole.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.